Table 1.
The baseline characteristics of the patients treated with the doxorubicin-based chemotherapy.
| No. (%) | |
|---|---|
| Sex | |
| Male | 40 (53) |
| Female | 35 (46) |
| Age | |
| Median age, years | 55 (21–75) |
| ECOG performance status | |
| 0 | 57 (76) |
| 1 | 15 (20) |
| 2 | 3 (4) |
| Location of the primary tumor | |
| Head and neck | 14 (19) |
| Thorax | 7 (9) |
| Abdomen | 23 (31) |
| Retroperitoneum | 19 (25) |
| Genital organs | 4 (5) |
| Others | 4 (5) |
| Unknown | 4 (5) |
| Number of involved organs | |
| 1 | 22 (29) |
| 2 | 26 (35) |
| 3 | 13 (17) |
| 4 | 10 (13) |
| ≧5 | 4 (5) |
| Site of involved organs, no. (%) | |
| Head and neck | 11 (15) |
| Intra-abdomen | 30 (40) |
| Retroperitoneum | 15 (20) |
| Lung | 35 (47) |
| Liver | 22 (29) |
| Bone | 18 (24) |
| Lymph node | 16 (21) |
| Others | 29 (39) |
| Maximum length | |
| Median (cm) | 5.3 (0–21.7) |
| >5 cm | 40 (53) |
| Pretreatment | |
| Operation | 49 (65) |
| Radiation | 21 (28) |
| Chemotherapy | 8 (11) |
| None | 18 (24) |
| Histopathology type | |
| Leiomyosarcoma | 17 (23) |
| Liposarcoma | 15 (20) |
| Spindle cell sarcoma, NOS | 14 (19) |
| Pleomorphic sarcoma | 6 (8) |
| Synovial sarcoma | 5 (7) |
| Others∗ | 18 (24) |
∗Others include angiosarcoma, undifferentiated pleomorphic sarcoma, solitary fibrous tumor, low-grade fibromyxoid sarcoma, malignant peripheral nerve sheath tumor, breast phyllodes tumor, round cell sarcoma with CIC rearrangement, neuroblastoma, malignant extrarenal rhabdoid tumor, and myxofibrosarcoma.